Jim Shaffer, MBA

Chief Business Officer

Biotech & Pharma Executive | Commercial Strategy | Business Development

 

Jim Shaffer is an accomplished biotech and pharmaceutical executive with over 25 years of global leadership experience across the U.S., Europe, and Canada. He specializes in launching and scaling clinical-stage and commercial biopharma companies with a focus on rare diseases, CNS, oncology, immunology, virology, and respiratory medicine.

 

Jim has a track record of success raising capital, leading global product launches, IPOs, M&A transactions, and strategic partnerships with leading pharma companies and academic institutions. He is known for building high-performance teams and developing transformative corporate and commercialization strategies that deliver results for patients, shareholders, and stakeholders.

AGT on Social Media: